United States · 
Who invested in RubrYc Therapeutics?
RubrYc Therapeutics's investors include Paladin Capital Group.
United States · Series A startup
Who invested in RubrYc Therapeutics
Funding summaryUpdated 26 Oct 2026
$7.5Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $7.5MAug 2021
- Investors
- 1
The rounds
- Aug 2021
Founders and team
From RubrYc Therapeutics's own website and the SEC filings it signed: 8 on the team.
- Felipe DuranChief Financial Officer
- Marc BanjakChief Legal Officer
- António ParadaDirector
- Chip ClarkChairman of the Board
- David ArkowitzDirector
- Gary SenderDirector
- Bill J. ColstonExecutive Officer, Director, Promoteri
- Isaac J. BrightExecutive Officer, Directori
On the board, as filediJason J. HongJean J. ViretPaul J. Conley
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about RubrYc Therapeutics
How much has RubrYc Therapeutics raised?
RubrYc Therapeutics has raised $7.5M across 1 round since 2021.
When did RubrYc Therapeutics last raise?
RubrYc Therapeutics's most recent round was a Series A of $7.5M in Aug 2021.
What was RubrYc Therapeutics's biggest round?
Its most recent round, $7.5M in Aug 2021, is also its largest on record.
Who backed RubrYc Therapeutics first?
RubrYc Therapeutics's first round on record, in Aug 2021, was backed by Paladin Capital Group.
What stage is RubrYc Therapeutics at?
RubrYc Therapeutics's latest named round is a Series A, in Aug 2021.
Where is RubrYc Therapeutics based?
RubrYc Therapeutics is based in the United States.
Companies like RubrYc Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.